Literature DB >> 33091960

Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.

Zihang Ling1,2, Bin Cheng1,2, Xiaoan Tao1,2.   

Abstract

Oral squamous cell carcinoma (OSCC) is the most common malignancy representing 90% of all forms of oral cancer worldwide. Although great efforts have been made in the past decades, the 5-year survival rate of OSCC patients is no more than 60% due to tumor metastasis and subsequent recurrence. The metastasis from the primary site is due to a complex process known as epithelial-to-mesenchymal transition (EMT). During the EMT, epithelial cells gradually acquire the structural and functional characteristics of mesenchymal cells, leading to the upregulation of cell migration and the promotion of tumor cell dissemination. Therefore, EMT attracted broad attention due to its close relationship with cancer invasion and metastasis. Therefore, in the present review, an extensive description of the current research on OSCC and the role of EMT in this cancer type is provided, including diverse EMT markers, regulatory networks and crucial EMT-inducing transcription factors in OSCC. Moreover, a brief summary was made regarding the current application of EMT-correlated indexes in the prognostic analysis of OSCC patients, and the potential therapeutic approaches against OSCC and difficulties in the development of an effective anti-EMT treatment are discussed. Our aim is to provide novel insights to develop new strategies to combat OSCC by targeting EMT.
© 2020 Union for International Cancer Control.

Entities:  

Keywords:  epithelial-mesenchymal transition (EMT); oral squamous cell carcinoma (OSCC); signaling pathway; transcription factors

Mesh:

Substances:

Year:  2020        PMID: 33091960     DOI: 10.1002/ijc.33352

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  HDAC6 is a prognostic biomarker that mediates IL-13 expression to regulate macrophage polarization through AP-1 in oral squamous cell carcinoma.

Authors:  Chung-Chih Tseng; Tsung-Hua Hsieh; Shi-Ying Huang; Hung-Pei Tsai; Chia-Wei Wu
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

2.  Identification of Prognostic and Tumor Microenvironment by Shelterin Complex-Related Signatures in Oral Squamous Cell Carcinoma.

Authors:  Suwei Zhang; Hanhui Yu; Jiazhen Li; Liang Zhao; Lei Tan; Qiang Song; Cong Sun
Journal:  Oxid Med Cell Longev       Date:  2022-06-15       Impact factor: 7.310

Review 3.  The significance of PAK4 in signaling and clinicopathology: A review.

Authors:  Xinbo Yu; Changwei Huang; Jiyuan Liu; Xinyu Shi; Xiaodong Li
Journal:  Open Life Sci       Date:  2022-06-20       Impact factor: 1.311

4.  Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.

Authors:  Dominic Fong; Katja Olga San Nicolò; Monika Alber; Manfred Mitterer
Journal:  Wien Klin Wochenschr       Date:  2021-01-27       Impact factor: 1.704

5.  NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer.

Authors:  Zhiyu Li; Bingxiong Liu; Chenyuan Li; Si Sun; Hanpu Zhang; Shengrong Sun; Zhong Wang; Xiongjie Zhang
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

6.  M1-like tumor-associated macrophages cascade a mesenchymal/stem-like phenotype of oral squamous cell carcinoma via the IL6/Stat3/THBS1 feedback loop.

Authors:  Yuanhe You; Zhuowei Tian; Zhong Du; Kailiu Wu; Guisong Xu; Meilu Dai; Yan'an Wang; Meng Xiao
Journal:  J Exp Clin Cancer Res       Date:  2022-01-06

Review 7.  Biomarker Potential of Vimentin in Oral Cancers.

Authors:  Saie Mogre; Vidhi Makani; Swapnita Pradhan; Pallavi Devre; Shyam More; Milind Vaidya; Crismita Dmello
Journal:  Life (Basel)       Date:  2022-01-20

8.  Epithelial-mesenchymal transition related to bone invasion in oral squamous cell carcinoma.

Authors:  Jaqueline Vaz Vanini; Leonardo Kenji Sakaue Koyama; Leandro Luongo de Matos; José Martins Figueredo Junior; Claudio Roberto Cernea; Cibele Pidorodeski Nagano; Cláudia Malheiros Coutinho-Camillo; Ricardo Hsieh; Silvia Vanessa Lourenço
Journal:  J Bone Oncol       Date:  2022-02-18       Impact factor: 4.072

9.  Antioral Squamous Cell Carcinoma Effects of Carvacrol via Inhibiting Inflammation, Proliferation, and Migration Related to Nrf2/Keap1 Pathway.

Authors:  Hui Liu; Xiaoliang Xu; Ran Wu; Lei Bi; Chunguang Zhang; Hui Chen; Yang Yang
Journal:  Biomed Res Int       Date:  2021-06-10       Impact factor: 3.411

10.  Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma.

Authors:  An Song; Yuanyuan Wu; Weiming Chu; Xueming Yang; Zaiou Zhu; Enshi Yan; Wei Zhang; Junbo Zhou; Xu Ding; Jie Liu; Hongxia Zhu; Jinhai Ye; Yunong Wu; Yang Zheng; Xiaomeng Song
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.